India's benchmark indexes traded lower on Tuesday, as broader losses led by pharma stocks on U.S. manufacturing measures ...

Donald Trump's initiative to prioritize American-made prescription drugs poses significant challenges for Indian ...

India's pharma market grew 7.8% in April 2025, driven by price hikes and chronic therapies, with top brands and segments like ...

CHENNAI: Concerns are mounting for the global pharmaceutical industry, particularly for Indian drug manufacturers that rely ...

Despite conclusive proof of Abbvie sponsoring foreign tours for 30 doctors, violating marketing practices, the National ...

The India–UK FTA is set to significantly boost bilateral trade to over $ 60 billion by 2030 through the elimination of ...

The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active ...

US executive order to speed up pharmaceutical plant approvals won't impact Indian industry due to various factors, experts ...

India’s ambition to emerge as a leading global logistics and pharmaceutical export hub received a strategic boost with Air ...

India has proposed eliminating tariffs on steel, auto components, and pharmaceuticals for a specific import quantity in trade ...

Indian drugmaker Alembic Pharmaceuticals reported a 12% fall in fourth-quarter profit on Tuesday, hurt by a deferred tax expense that offset the impact of strong sales in its key U.S. and domestic ...

Indian pharma stocks took a sharp hit after U.S. President Donald Trump signed a new executive order aimed at reviving ...